Evidence map›Paper›PMID 23938111›Full record

ArticleGenetics research2013

Sparse group penalized integrative analysis of multiple cancer prognosis datasets.

Jin Liu, Jian Huang, Yang Xie, Shuangge Ma

Abstract read
In one paragraph

Article in Genetics research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jin LiuDivision of Epidemiology and Biostatistics, UIC School of Public Health 1603 W Taylor Street, MC 923, Chicago, IL 60612-4394, USA.
Jian Huang
Yang Xie
Shuangge Ma

Funding

Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
Novel Methods for Integrative Analysis of Cancer Genomic DataR01CA142774 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2010 to 2013
$1.3M
Robust rank-based methods and detection of GXE in cancer etiology and survivalR21CA165923 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE, ZHANG, YAWEI · 2012 to 2014
$421k
NCI NIH HHS CA142774NCI NIH HHS CA152301NCI NIH HHS CA165923NCI NIH HHS R01 CA142774NCI NIH HHS R01 CA152301NCI NIH HHS R21 CA165923
6 · The paper itself

Abstract

In cancer research, high-throughput profiling studies have been extensively conducted, searching for markers associated with prognosis. Owing to the 'large d, small n' characteristic, results generated from the analysis of a single dataset can be unsatisfactory. Recent studies have shown that integrative analysis, which simultaneously analyses multiple datasets, can be more effective than single-dataset analysis and classic meta-analysis. In most of existing integrative analysis, the homogeneity model has been assumed, which postulates that different datasets share the same set of markers. Several approaches have been designed to reinforce this assumption. In practice, different datasets may differ in terms of patient selection criteria, profiling techniques, and many other aspects. Such differences may make the homogeneity model too restricted. In this study, we assume the heterogeneity model, under which different datasets are allowed to have different sets of markers. With multiple cancer prognosis datasets, we adopt the accelerated failure time model to describe survival. This model may have the lowest computational cost among popular semiparametric survival models. For marker selection, we adopt a sparse group minimax concave penalty approach. This approach has an intuitive formulation and can be computed using an effective group coordinate descent algorithm. Simulation study shows that it outperforms the existing approaches under both the homogeneity and heterogeneity models. Data analysis further demonstrates the merit of heterogeneity model and proposed approach.

Indexed as

Models, TheoreticalHumansNeoplasmsPrognosis

Identifiers

PMID23938111
PMCPMC4090387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.